相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Calcium Ions Promote Formation of Amyloid β-Peptide (1-40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease
Anna Itkin et al.
PLOS ONE (2011)
Intrathecal corticosteroids might slow Alzheimer’s disease progression
Joseph Alisky
Neuropsychiatric Disease and Treatment (2011)
In Vivo Responses of the Human and Murine Pregnane X Receptor to Dexamethasone in Mice
Nico Scheer et al.
DRUG METABOLISM AND DISPOSITION (2010)
Protective actions of sex steroid hormones in Alzheimer's disease
Christian J. Pike et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2009)
Caffeine Suppresses Amyloid-β Levels in Plasma and Brain of Alzheimer's Disease Transgenic Mice
Chuanhai Cao et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Caffeine Reverses Cognitive Impairment and Decreases Brain Amyloid-β Levels in Aged Alzheimer's Disease Mice
Gary W. Arendash et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function
L. M. Jungbauer et al.
JOURNAL OF MOLECULAR RECOGNITION (2009)
Pregnane X Receptor (PXR) Regulates P-Glycoprotein at the Blood-Brain Barrier: Functional Similarities between Pig and Human PXR
Melanie Ott et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Rifampin and digoxin induction of MDR1 expression and function in human intestinal (T84) epithelial cells
I. S. Haslam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The pregnane X receptor: from bench to bedside
Xiaochao Ma et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Modulation of P-glycoprotein at the blood-brain barrier: Opportunities to improve central nervous system pharmacotherapy
David S. Miller et al.
PHARMACOLOGICAL REVIEWS (2008)
Increased P-glycoprotein expression and decreased phenobarbital distribution in the brain of pentylenetetrazole-kindled rats
Xiaodong Liu et al.
NEUROPHARMACOLOGY (2007)
MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-β peptides -: Implications for the mechanisms of Aβ clearance at the blood-brain barrier
Diana Kuhnke et al.
BRAIN PATHOLOGY (2007)
Hyperforin prevents β-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-β-deposits
M. C. Dinamarca et al.
MOLECULAR PSYCHIATRY (2006)
Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of ( R )-[11C]verapamil and positron emission tomography
Rolf Toornvliet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism
C Tannergren et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice
SB de Lagerie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease
MB Loeb et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Method for measurement of the blood-brain barrier permeability in the perfused mouse brain:: application to amyloid-β peptide in wild type and Alzheimer's Tg2576 mice
B LaRue et al.
JOURNAL OF NEUROSCIENCE METHODS (2004)
Rapid assessment of P-glycoprotein inhibition and induction in vitro
MD Perloff et al.
PHARMACEUTICAL RESEARCH (2003)
Deposition of Alzheimer's β-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
S Vogelgesang et al.
PHARMACOGENETICS (2002)
Does caffeine intake protect from Alzheimer's disease?
L Maia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
β-Amyloid efflux mediated by p-glycoprotein
FC Lam et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT
YT Pham et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2000)
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
D Dürr et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
